Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/25/2025

Immune Thrombocytopenia Treatment Guidelines

Introduction to Prednisone Treatment

  • Prednisone increases platelet counts primarily by enhancing platelet production rather than prolonging platelet survival, making it an effective first-line treatment for immune thrombocytopenia with response rates of 72-88% within 72 hours at appropriate dosing 1

Corticosteroid Regimens

  • For adults with ITP, the American Society of Hematology recommends prednisone at a dose of 0.5-2.0 mg/kg per day 2
  • For children with ITP, the standard dose of prednisone is 1-2 mg/kg/day, while a higher dose of 4 mg/kg/day for 3-4 days has shown effectiveness in 72-88% of children within 72 hours 1

Indications for Prednisone

  • Prednisone is indicated in adults with newly diagnosed ITP, as recommended by the American Society of Hematology 2
  • Prednisone is indicated in children with severe bleeding symptoms, moderate bleeding or increased bleeding risk, and in emergency situations, as recommended by the American Academy of Pediatrics 1

Treatment Duration and Goals

  • The duration of prednisone treatment should be as short as possible, especially in children, due to side effect concerns, as recommended by the American Academy of Pediatrics 1
  • The treatment goal is to maintain a hemostatic platelet count rather than normalizing counts, as recommended by the American Society of Hematology 1

Alternative and Adjunctive Therapies

  • When prednisone is not suitable or as adjunctive therapy, IVIg may be used, with a more rapid response than corticosteroids alone, effective in >80% of children, as recommended by the American Academy of Pediatrics 1
  • IV anti-D immunoglobulin may be used for Rh(D)-positive patients, as recommended by the American Society of Hematology 1
  • Combined therapy with prednisone and IVIg may be more effective in emergency situations with severe bleeding, as recommended by the American Society of Hematology 1